Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter
Owens, M. J., & Nemeroff, C. B. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.2.288 · Cited by 929
Ramamoorthy, S., Bauman, A. L., Moore, K. R., Han, H., Yang-Feng, T., Chang, A. S., Ganapathy, V, & Blakely, R. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2542 · Cited by 880
Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.6.733 · Cited by 317
Romero, L., & Artigas, F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062593.x · Cited by 152
Neurotransmitter‐mediated signaling between axons and glial cells
Chiu, S. Y., & Kriegler, S. (1994) · Glia · doi:10.1002/glia.440110213 · Cited by 141
Deckert, J., Catalano, M., Heils, A., Bella, D. D., Friess, F., Politi, E., Franke, P., Nöthen, M. M., Maier, W., Bellodi, L., et al. (1997) · Psychiatric Genetics · doi:10.1097/00041444-199700710-00008 · Cited by 108
Self-citationPindolol, 5-Hydroxytryptamine, and Antidepressant Augmentation
Artigas, F. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950230083012 · Cited by 54
Lucca, A., Lucini, V., Catalano, M., Alfano, M., & Smeraldi, E. (2008) · Neuropsychobiology · doi:10.1159/000119071 · Cited by 47
Self-citation
Cited by
Mediators and Moderators of Treatment Effects in Randomized Clinical Trials
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.877 · Cited by 2,562
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Kraemer, H. C., Stice, E., Kazdin, A., Offord, D., & Kupfer, D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.848 · Cited by 1,712
Verdejo-García, A., Lawrence, A. J., & Clark, L. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.11.003 · Cited by 1,422
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Research and treatment approaches to depression
Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656
“This polymorphism has been associated with the antidepressant effects of the selective serotonin reuptake inhibitor”
BackgroundChmura Kraemer, H., Kiernan, M., Essex, M., & Kupfer, D. J. (2008) · Health Psychology · doi:10.1037/0278-6133.27.2(suppl.).s101 · Cited by 600
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529
Uher, R., & McGuffin, P. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002067 · Cited by 506
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
Bethea, C. L., Lu, N. Z., Gundlah, C., & Streicher, J. M. (2002) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0225 · Cited by 490
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450
Sleep deprivation in depression: what do we know, where do we go?
Wirz-Justice, A., & Van den Hoofdakker, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00125-0 · Cited by 429
Pollock, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00132-9 · Cited by 415
Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug Response
Evans, W. E., & Johnson, J. A. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.9 · Cited by 415
Serotonergic vulnerability and depression: assumptions, experimental evidence and implications
Jans, L. A. W., Riedel, W. J., Markus, C. R., & Blokland, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001920 · Cited by 374
Chen, C.-H., Ridler, K., Suckling, J., Williams, S., Fu, C. H. Y., Merlo-Pich, E., & Bullmore, E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.018 · Cited by 354
Neurobiological bases for the relation between sleep and depression
Adrien, J. (2002) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(01)90200-x · Cited by 350
Drug development for CNS disorders: strategies for balancing risk and reducing attrition
Pangalos, M. N., Schechter, L. E., & Hurko, O. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2094 · Cited by 336
Porcelli, S., Fabbri, C., & Serretti, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.10.003 · Cited by 331
“Subjects with pindolol augmentation were excluded given the observed influence of pindolol on the 5-HTTLPR effect (Smeraldi et al., 1998).”
BackgroundResultInfluentialModerators of Treatment Outcomes: Clinical, Research, and Policy Importance
Kraemer, H. C., Frank, E., & Kupfer, D. J. (2006) · JAMA · doi:10.1001/jama.296.10.1286 · Cited by 310
Zanardi, R., Benedetti, F., Di Bella, D., Catalano, M., & Smeraldi, E. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00021 · Cited by 308
Self-citationPharmacogenetics of Psychotropic Drug Response
Malhotra, A. K., Murphy, G. M., & Kennedy, J. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.780 · Cited by 300
Chronotherapeutics (light and wake therapy) in affective disorders
WIRZ-JUSTICE, A., BENEDETTI, F., BERGER, M., LAM, R. W., MARTINY, K., TERMAN, M., & WU, J. C. (2005) · Psychological Medicine · doi:10.1017/s003329170500437x · Cited by 291
“The antidepressant response was successfully maintained with lithium salts (Szuba et al. 1994; Benedetti et al. 1999a), the 5-HT1A antagonist pindolol (Smeraldi et al. 1999), phase advance of the sleep-wake cycle (Benedetti et al. 2001a) and morning light therapy (Neumeister et al. 1996; Colombo et…”
MethodSelf-citationPharmacogenetics and the serotonin system: initial studies and future directions
Veenstra-VanderWeele, J., Anderson, G. M., & Cook, E. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00814-1 · Cited by 289
Evaluation of Antidepressant-related Behavioral Responses in Mice Lacking the Serotonin Transporter
Holmes, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00374-3 · Cited by 286
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome
Camilleri, M., Atanasova, E., Carlson, P. J., Ahmad, U., Kim, H. J., Viramontes, B. E., Mckinzie, S., & Urrutia, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34780 · Cited by 285
Murphy, G. M., Hollander, S. B., Rodrigues, H. E., Kremer, C., & Schatzberg, A. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1163 · Cited by 275
Personalized medicine in psychiatry: problems and promises
Ozomaro, U., Wahlestedt, C., & Nemeroff, C. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-132 · Cited by 270
Serotonin-Related Gene Polymorphisms and Central Nervous System Serotonin Function
Williams, R. B., Marchuk, D. A., Gadde, K. M., Barefoot, J. C., Grichnik, K., Helms, M. J., Kuhn, C. M., Lewis, J. G., Schanberg, S. M., Stafford-Smith, M., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300054 · Cited by 261
Saxena, S., Brody, A. L., Ho, M. L., Zohrabi, N., Maidment, K. M., & Baxter, L. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.522 · Cited by 210
Treating minority patients with depression and anxiety: What does the evidence tell us?
Schraufnagel, T. J., Wagner, A. W., Miranda, J., & Roy-Byrne, P. P. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.07.002 · Cited by 205
Dong, C., Wong, M.-L., & Licinio, J. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.92 · Cited by 182
Clark, L., Roiser, J. P., Cools, R., Rubinsztein, D. C., Sahakian, B. J., & Robbins, T. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0104-6 · Cited by 175
“1996) and display a slowed response to antidepressant treatment (Durham et al. 2004; Pollock et al. 2000; Smeraldi et al. 1998).”
BackgroundArias, B., Catalán, R., Gastó, C., Gutiérrez, B., & Fañanás, L. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095350.32154.73 · Cited by 174
Kemp, A. H., Gordon, E., Rush, A. J., & Williams, L. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900017120 · Cited by 170
Benedetti, F., Serretti, A., Colombo, C., Campori, E., Barbini, B., di Bella, D., & Smeraldi, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1450 · Cited by 167
Self-citationInsomnia improvement during antidepressant treatment andCLOCK gene polymorphism
Serretti, A., Cusin, C., Benedetti, F., Mandelli, L., Pirovano, A., Zanardi, R., Colombo, C., & Smeraldi, E. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30130 · Cited by 164
“Assessment methods were previously reported [Smeraldi et al., 1998; Serretti et al., 2001].”
MethodResultSelf-citationCools, R., Calder, A. J., Lawrence, A. D., Clark, L., Bullmore, E., & Robbins, T. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2215-5 · Cited by 161
Hinshaw, S. P. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsl055 · Cited by 141
“Moderator variables have been extended to include genotypes, which may predict differential responsiveness to medication intervention for depression.(16) Indeed, moderators range from individuallevel variables all the way to social processes (e.”
BackgroundColombo, C., Lucca, A., Benedetti, F., Barbini, B., Campori, E., & Smeraldi, E. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00164-5 · Cited by 139
“A dim 150-lux red light and a bright 2500-lux white light were equally effective in preventing a relapse after TSD. Patients affected by bipolar disorder have been shown to be supersensitive to Žthe biological effects of light Lewy et al., 1981, .1985; Nathan et al. 1999 , and a positive interaction between TSD and li…”
BackgroundInfluentialSelf-citationPharmacogenetics of antidepressants
Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113
Roiser, J. P., Blackwell, A. D., Cools, R., Clark, L., Rubinsztein, D. C., Robbins, T. W., & Sahakian, B. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301055 · Cited by 98
“The s allele has been associated with increased risk for depression (Caspi et al , 2003; Furlong et al , 1998) and poorer responses to selective serotonin reuptake inhibitor (SSRI) treatment in depressed patients (Smeraldi et al , 1998).”
Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response
Keers, R., & Uher, R. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-011-0251-x · Cited by 94
Serotonergic gene expression and depression: implications for developing novel antidepressants
Lesch, K. P. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00351-7 · Cited by 93
Amsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009) · Neuropsychobiology · doi:10.1159/000226611 · Cited by 39
“There is considerable debate as to whether tachyphylaxis to antidepressant drug therapy results from a genetic predisposition [”
BackgroundBiological predictors of lithium response in bipolar disorder
Ikeda, A., & Kato, T. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01112.x · Cited by 35
Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network
Ma, Y., Li, B., Wang, C., Zhang, W., Rao, Y., & Han, S. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.150128 · Cited by 23
Metadata
- Authors
- Smeraldi, E., Zanardi, R., Benedetti, F., Bella, D. D., Perez, J., & Catalano, M.
- Venue
- Molecular Psychiatry
- Published
- 1998-11-01
- Volume
- 3
- Issue
- 6
- Pages
- 508-511
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2070861572
- Cited by
- 614
- References
- 12
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.